These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37330018)

  • 21. The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project).
    Rifai MA; Qureshi WT; Dardari Z; Keteyian SJ; Brawner CA; Ehrman JK; Ahmed A; Sakr S; Virani SS; Blaha MJ; Al-Mallah MH
    Am J Cardiol; 2019 Aug; 124(4):511-517. PubMed ID: 31221461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
    Kristensen LE; Strober B; Poddubnyy D; Leung YY; Jo H; Kwok K; Vranic I; Fleishaker DL; Fallon L; Yndestad A; Gladman DD
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149965. PubMed ID: 36777695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
    Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
    Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
    Mahtta D; Lee MT; Ramsey DJ; Akeroyd JM; Krittanawong C; Khan SU; Sinh P; Alam M; Garratt KN; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):93-102. PubMed ID: 33400053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.
    Al Rifai M; Yao J; Guo X; Post WS; Malik S; Blumenthal RS; Ballantyne CM; Budoff M; Taylor KD; Lin HJ; Rich SS; Hajek C; Greenland P; Rotter JI; Virani SS
    Prog Cardiovasc Dis; 2022; 74():19-27. PubMed ID: 35952728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases.
    Deo SV; Motairek I; Nasir K; Mentias A; Elgudin Y; Virani SS; Rajagopalan S; Al-Kindi S
    JAMA Netw Open; 2023 Jul; 6(7):e2322727. PubMed ID: 37432687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
    Stevens SR; Segar MW; Pandey A; Lokhnygina Y; Green JB; McGuire DK; Standl E; Peterson ED; Holman RR
    Cardiovasc Diabetol; 2022 Aug; 21(1):166. PubMed ID: 36030198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.
    Zibaeenejad F; Mohammadi SS; Sayadi M; Safari F; Zibaeenezhad MJ
    BMC Cardiovasc Disord; 2022 Apr; 22(1):162. PubMed ID: 35397522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
    Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
    JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).
    Budoff MJ; Young R; Burke G; Jeffrey Carr J; Detrano RC; Folsom AR; Kronmal R; Lima JAC; Liu KJ; McClelland RL; Michos E; Post WS; Shea S; Watson KE; Wong ND
    Eur Heart J; 2018 Jul; 39(25):2401-2408. PubMed ID: 29688297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
    Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis.
    Cardona A; O'Brien A; Bernier MC; Somogyi A; Wysocki VH; Smart S; He X; Ambrosio G; Hsueh WA; Raman SV
    BMJ Open Diabetes Res Care; 2019; 7(1):e000718. PubMed ID: 31798892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
    J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
    JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study.
    Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS
    BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A
    JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
    Charles-Schoeman C; Buch MH; Dougados M; Bhatt DL; Giles JT; Ytterberg SR; Koch GG; Vranic I; Wu J; Wang C; Kwok K; Menon S; Rivas JL; Yndestad A; Connell CA; Szekanecz Z
    Ann Rheum Dis; 2023 Jan; 82(1):119-129. PubMed ID: 36137735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.